https://sputnikglobe.com/20210219/russia-may-start-delivering-sputnik-v-covid-19-vaccine-to-african-union-in-may-rdif-says-1082127755.html
Russia May Start Delivering Sputnik V COVID-19 Vaccine to African Union in May, RDIF Says
Russia May Start Delivering Sputnik V COVID-19 Vaccine to African Union in May, RDIF Says
Sputnik International
MOSCOW (Sputnik) - Russia may start delivering its coronavirus vaccine Sputnik V to the African Union in May, with the bulk of supplies set to start in June... 19.02.2021, Sputnik International
2021-02-19T12:15+0000
2021-02-19T12:15+0000
2021-02-19T12:15+0000
https://cdn1.img.sputnikglobe.com/img/07e4/09/07/1080394030_0:188:3073:1916_1920x0_80_0_0_586542ad463950448b211f800eef4af6.jpg
africa
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
newsfeed, coronavirus, russian direct investment fund (rdif)
newsfeed, coronavirus, russian direct investment fund (rdif)
Russia May Start Delivering Sputnik V COVID-19 Vaccine to African Union in May, RDIF Says
MOSCOW (Sputnik) - Russia may start delivering its coronavirus vaccine Sputnik V to the African Union in May, with the bulk of supplies set to start in June, the head of the Russian Direct Investment Fund (RDIF) told Sputnik on Friday.
"Partial deliveries of Russia's Sputnik V vaccine to the African Union may start in May, but the major part will begin in June 2021," RDIF CEO Kirill Dmitriev said.
Earlier in the day, the Africa Medical Supplies Platform announced it had received from Russia a proposal to supply 300 million doses of the vaccine.
Earlier this year, Algeria became the first African nation to register the vaccine.
Sputnik V, developed by the Gamaleya Research Institute of Epidemiology and Microbiology, was registered by the Russian Health Ministry on 11 August, becoming the first registered vaccine against COVID-19 in the world. According to the trial results, the vaccine shows over 90 percent efficiency, and is expected to provide two years of immunity against the virus.
